SCL Science Inc. (KOSDAQ:246960)
South Korea
· Delayed Price · Currency is KRW 1,860.00
-30.00 (-1.59%)
At close: Mar 6, 2026
SCL Science Revenue
SCL Science had revenue of 6.96B KRW in the quarter ending September 30, 2025, with 592.41% growth. This brings the company's revenue in the last twelve months to 16.32B, up 488.79% year-over-year. In the year 2024, SCL Science had annual revenue of 4.74B with 258.30% growth.
Revenue (ttm)
16.32B
Revenue Growth
+488.79%
P/S Ratio
3.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.74B | 3.42B | 258.30% |
| Dec 31, 2023 | 1.32B | 952.33M | 257.54% |
| Dec 31, 2022 | 369.78M | -137.51M | -27.11% |
| Dec 31, 2021 | 507.29M | -88.90M | -14.91% |
| Dec 31, 2020 | 596.19M | -96.57M | -13.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wonbiogen | 34.38B |
| KM Corporation | 133.05B |
| MEDYSSEY Co.,Ltd | 10.60B |
| Sewoon Medical | 62.13B |
| JW Shinyak | 76.02B |
| OSTEONIC | 42.11B |
| Plasmapp | 6.20B |
| Billions | 30.71B |